Evidence map›Paper›PMID 37687335›Full record

ArticlePlants (Basel, Switzerland)2023

Effect of Betulin Colloidal Particles on Proliferation and Cytokine Secretion of Human Skin Fibroblasts.

Una Riekstina, Sanita Vitolina, Karina Goluba, Kaspars Jekabsons, Ruta Muceniece, Rudolfs Berzins, Janis Rizhikovs, Daniela Godina, Arturs Teresko, Aigars Paze

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Una RiekstinaFaculty of Medicine, University of Latvia, LV-1004 Riga, Latvia.ORCID 0000-0003-2217-7053
Sanita VitolinaBiorefinery Laboratory, Latvian State Institute of Wood Chemistry, LV-1006 Riga, Latvia.ORCID 0000-0002-5904-1179
Karina GolubaFaculty of Medicine, University of Latvia, LV-1004 Riga, Latvia.ORCID 0000-0002-3863-7934
Kaspars JekabsonsFaculty of Medicine, University of Latvia, LV-1004 Riga, Latvia.ORCID 0000-0003-3127-6694
Ruta MucenieceFaculty of Medicine, University of Latvia, LV-1004 Riga, Latvia.
Rudolfs BerzinsBiorefinery Laboratory, Latvian State Institute of Wood Chemistry, LV-1006 Riga, Latvia.
Janis RizhikovsBiorefinery Laboratory, Latvian State Institute of Wood Chemistry, LV-1006 Riga, Latvia.ORCID 0000-0002-4825-3053
Daniela GodinaBiorefinery Laboratory, Latvian State Institute of Wood Chemistry, LV-1006 Riga, Latvia.
Arturs TereskoZS DOKTUS, LV-4101 Cesis, Latvia.
Aigars PazeBiorefinery Laboratory, Latvian State Institute of Wood Chemistry, LV-1006 Riga, Latvia.ORCID 0000-0003-3209-5289
Latvian State Institute of Wood Chemistry · LVUniversity of Latvia · LV

Funding

European Regional Development Fund 1.1.1.1/20/A/071University of Latvia fundamental research grant
6 · The paper itself

Abstract

The aim of the study was to obtain untreated and treated betulin colloidal particles and assess their effect on the viability, morphology, proliferation and cytokine secretion of human dermal fibroblasts. To improve bioavailability, betulin treatment was performed by an antisolvent precipitation technique. The average particle size after treatment in the aqueous dispersion decreased from 552.9 ± 11.3 to 278.2 ± 1.6 nm. Treated betulin colloidal particles showed no cytotoxicity up to a concentration of 400 µg·mL

Indexed as

betulincolloidal particlescytokine secretioncytotoxicitydynamic light scatteringgas chromatographyhuman skin fibroblastsin vitrowound healing

Identifiers

PMID37687335
PMCPMC10490372
OpenAlexW4386250501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.